Baxter International Inc (BAX) Expected to Announce Quarterly Sales of $2.62 Billion

Share on StockTwits

Wall Street analysts forecast that Baxter International Inc (NYSE:BAX) will announce $2.62 billion in sales for the current quarter, according to Zacks. Five analysts have made estimates for Baxter International’s earnings. The highest sales estimate is $2.67 billion and the lowest is $2.59 billion. Baxter International posted sales of $2.68 billion during the same quarter last year, which suggests a negative year-over-year growth rate of 2.2%. The business is scheduled to issue its next quarterly earnings report before the market opens on Thursday, April 25th.

On average, analysts expect that Baxter International will report full-year sales of $11.22 billion for the current fiscal year, with estimates ranging from $11.17 billion to $11.29 billion. For the next financial year, analysts anticipate that the company will report sales of $11.76 billion, with estimates ranging from $11.61 billion to $11.92 billion. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Baxter International.

Baxter International (NYSE:BAX) last posted its quarterly earnings results on Thursday, January 31st. The medical instruments supplier reported $0.78 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.05. Baxter International had a net margin of 14.60% and a return on equity of 19.10%. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.80 billion.

A number of brokerages recently weighed in on BAX. Morgan Stanley lifted their price target on Baxter International from $80.00 to $83.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 5th. Zacks Investment Research lowered Baxter International from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. Credit Suisse Group began coverage on Baxter International in a report on Monday, December 17th. They set an “outperform” rating and a $77.00 price target for the company. Wells Fargo & Co upped their price target on Baxter International from $72.00 to $76.00 and gave the stock an “outperform” rating in a report on Tuesday, December 4th. Finally, UBS Group began coverage on Baxter International in a report on Tuesday, November 27th. They set a “buy” rating and a $80.00 price target for the company. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Baxter International presently has an average rating of “Buy” and a consensus price target of $77.31.

In other Baxter International news, SVP Giuseppe Accogli sold 38,297 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $76.78, for a total value of $2,940,443.66. Following the sale, the senior vice president now directly owns 70,001 shares in the company, valued at $5,374,676.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jeanne K. Mason sold 37,274 shares of the company’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $72.00, for a total value of $2,683,728.00. The disclosure for this sale can be found here. Insiders sold 82,896 shares of company stock worth $6,157,104 over the last quarter. Company insiders own 0.07% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Gantzert Investment Co. LLC ADV bought a new position in Baxter International in the fourth quarter valued at approximately $25,000. Parisi Gray Wealth Management acquired a new position in Baxter International during the 4th quarter worth approximately $26,000. Sontag Advisory LLC acquired a new position in Baxter International during the 4th quarter worth approximately $30,000. Baldwin Brothers Inc. MA raised its stake in Baxter International by 904.0% during the 4th quarter. Baldwin Brothers Inc. MA now owns 502 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 452 shares during the period. Finally, We Are One Seven LLC acquired a new position in Baxter International during the 4th quarter worth approximately $34,000. 86.16% of the stock is currently owned by institutional investors.

NYSE BAX traded up $0.11 during mid-day trading on Friday, hitting $77.35. The company’s stock had a trading volume of 987,867 shares, compared to its average volume of 2,832,174. Baxter International has a 52-week low of $61.05 and a 52-week high of $78.52. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.50 and a current ratio of 2.09. The firm has a market capitalization of $39.74 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 1.93 and a beta of 1.00.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Shareholders of record on Friday, March 1st will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date is Thursday, February 28th. Baxter International’s dividend payout ratio (DPR) is 24.92%.

About Baxter International

Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: Federal Reserve

Get a free copy of the Zacks research report on Baxter International (BAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.